RESPAPS
Dead / Abandoned — Abandoned — no statement of use filed (as of 21 Aug 2023)
What this means for you
This application is over — abandoned 21 Aug 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90803621
- Mark type
- Stylized text
- Filed
- 30 Jun 2021
- Published for opposition
- 22 Nov 2022
- Abandoned
- 21 Aug 2023
- Attorney of record
- SARA M. DORCHAK
Goods and services
- Class 010 — Medical apparatus: Medical apparatus for the treatment of obstructive sleep apnea; Medical apparatus, namely, non-invasive ventilation apparatus and instruments; Medical respiratory masks for use in treating obstructive sleep apnea; Breathing masks for use in treating obstructive sleep apnea; Seals and connectors for medical respiratory masks; Medical apparatus, namely, continuous positive airway pressure (CPAP) devices, bi-level positive air pressure (BiPAP) devices, variable positive airway pressure (VPAP) devices, smart positive air pressure devices, automatic positive air pressure (APAP) devices, and automatic bi-level positive air pressure (ABiPAP) devices; Medical devices for the treatment of sleep apnea; Humidifiers for medical use
Owner
- GENADYNE BIOTECHNOLOGIES, INC., HICKSVILLE, NY, US
- GENADYNE BIOTECHNOLOGIES, INC., HICKSVILLE, NY, US
Prosecution history
- 21 Aug 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 21 Aug 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 17 Jan 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 22 Nov 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Nov 2022 — PUBLISHED FOR OPPOSITION
- 02 Nov 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Oct 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Oct 2022 — EXAMINER'S AMENDMENT ENTERED
- 13 Oct 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 13 Oct 2022 — EXAMINERS AMENDMENT E-MAILED
- 13 Oct 2022 — EXAMINERS AMENDMENT -WRITTEN
- 30 Mar 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 30 Mar 2022 — NON-FINAL ACTION E-MAILED
- 30 Mar 2022 — NON-FINAL ACTION WRITTEN
- 22 Mar 2022 — ASSIGNED TO EXAMINER